-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Veradermics, Raises Price Target to $172

Benzinga·10/19/2026 11:25:34
Listen to the news
Needham analyst Serge Belanger maintains Veradermics (NYSE:MANE) with a Buy and raises the price target from $164 to $172.